"Digital measures have tremendous potential to bring new insights to disease, both in understanding the diseases as well as more fully evaluating the efficacy of treatments in a quantitative unbiased manner.  This meeting brings together the experts in the field to share knowledge and insights, both the wins and the challenges, to help bring the potential to reality.”

Carrie Northcott, Head of Digital Science, Pfizer

"This event brings together thought leaders in the relatively young fields of digital biomarkers and clinical measures at a critical moment in time: technologies have advanced, thinking has matured, and we are accelerating towards impact.”

Vice President, Neuroscience Data Science & Digital Health, Johnson & Johnson

"Networking, a sense of community, ability to be heard and hear from a variety of people.”

Medical Science Director, Genentech

"The topics covered as well as the speakers were very interesting and diverse.”

Senior Digital Health Manager, Ipsen

"This was a great event! Well organized and attendance was great as well.”

Associate Director, Alexion Pharmaceuticals

"The networking break and conduct of these sessions were invaluable to "break the ice" and make it informal and collaborative.”

Associate Director, Sanofi

"The Speakers were knowledgeable and offered very practical and useful insights into what shape a digital biomarker strategy should take. Most speakers were a good mix of specific examples in neurology but then offered insights to how to apply these to others.”

Medical Science Liaison, Teva Pharmaceutical